The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Protein profiles associated with survival in lung adenocarcinoma
Open accessAbstract
Morphologic assessment of lung tumors is informative but insufficient to adequately predict patient outcome. We previously identified transcriptional profiles that predict patient survival, and here we identify proteins associated with patient survival in lung adenocarcinoma. A total of 682 individual protein spots were quantified in 90 lung adenocarcinomas by using quantitative two-dimensional polyacrylamide gel electrophoresis analysis. A leave-one-out cross-validation procedure using the top 20 survival-associated proteins identified by Cox modeling indicated that protein profiles as a whole can predict survival in stage I tumor patients (P= 0.01). Thirty-three of 46 survival-associated proteins were identified by using mass spectrometry. Expression of 12 candidate proteins was confirmed as tumor-derived with immunohistochemical analysis and tissue microarrays. Oligonucleotide microarray results from both the same tumors and from an independent study showed mRNAs associated with survival for 11 of 27 encoded genes. Combined analysis of protein and mRNA data revealed 11 components of the glycolysis pathway as associated with poor survival. Among these candidates, phosphoglycerate kinase 1 was associated with survival in the protein study, in both mRNA studies and in an independent validation set of 117 adenocarcinomas and squamous lung tumors using tissue microarrays. Elevated levels of phosphoglycerate kinase 1 in the serum were also significantly correlated with poor outcome in a validation set of 107 patients with lung adenocarcinomas using ELISA analysis. These studies identify new prognostic biomarkers and indicate that protein expression profiles can predict the outcome of patients with early-stage lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Bhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191502998 · Cited by 2,576
Gene-expression profiles predict survival of patients with lung adenocarcinoma
Beer, D. G., Kardia, S. L. R., Huang, C.-C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., et al. (2002) · Nature Medicine · doi:10.1038/nm733 · Cited by 2,025
Self-citationThe glucose-regulated proteins: stress induction and clinical applications
Lee, A. S. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01908-9 · Cited by 1,032
Discordant Protein and mRNA Expression in Lung Adenocarcinomas
Chen, G., Gharib, T. G., Huang, C.-C., Taylor, J. M. G., Misek, D. E., Kardia, S. L. R., Giordano, T. J., Iannettoni, M. D., Orringer, M. B., Hanash, S. M., et al. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200008-mcp200 · Cited by 946
Self-citationLu, H., Forbes, R. A., & Verma, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202487200 · Cited by 837
Prognosis and survival in resected lung carcinoma based on the new international staging system
Naruke, T., Goya, T., Tsuchiya, R., & Suemasu, K. (1988) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)35243-2 · Cited by 688
Hoffman, P. C., Mauer, A. M., & Vokes, E. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)82038-3 · Cited by 605
Prognostic Factors in Non-small Cell Lung Cancer
Brundage, M. D., Davies, D., & Mackillop, W. J. (2002) · Chest · doi:10.1378/chest.122.3.1037 · Cited by 564
Giatromanolaki, A., Koukourakis, M. I., Sivridis, E., Turley, H., Talks, K., Pezzella, F., Gatter, K. C., & Harris, A. L. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2018 · Cited by 478
Postsurgical Stage I Bronchogenic Carcinoma: Morbid Implications of Recurrent Disease
Pairolero, P. C., Williams, D. E., Bergstralh, E. J., Piehler, J. M., Bernatz, P. E., & Payne, W. S. (1984) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)62281-3 · Cited by 372
Chen, G., Gharib, T. G., Huang, C.-C., Thomas, D. G., Shedden, K., Taylor, J. M. G., Kardia, S. L. R., Misek, D. E., Giordano, T. J., Iannettoni, M. D., et al. (2002) · PubMed · Cited by 317
Self-citationSurvival of patients surgically treated for Stage I lung cancer
Williams, D. E., Pairolero, P. C., Davis, C. S., Bernatz, P. E., Spencer Payne, W., Taylor, W. F., Uhlenhopp, M. A., & Fontana, R. S. (1981) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)39389-4 · Cited by 312
Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase
Lay, A. J., Jiang, X.-M., Kisker, O., Flynn, E., Underwood, A., Condron, R., & Hogg, P. J. (2000) · Nature · doi:10.1038/35048596 · Cited by 267
Self-citationAsymptotics for and against cross-validation
STONE, M. (1977) · Biometrika · doi:10.1093/biomet/64.1.29 · Cited by 264
Fry, W. A., Phillips, J. L., & Menck, H. R. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991101)86:9<1867::aid-cncr31>3.0.co;2-9 · Cited by 263
Alaiya, A. A., Franzén, B., Auer, G., & Linder, S. T. (2000) · Electrophoresis · Cited by 114
Overexpression of Oncoprotein 18 Correlates with Poor Differentiation in Lung Adenocarcinomas
Chen, G., Wang, H., Gharib, T. G., Huang, C., Thomas, D. G., Shedden, K., Kuick, R. D., Taylor, J. M. G., Kardia, S. L. R., Misek, D. E., et al. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200055-mcp200 · Cited by 87
Self-citationOverexpression of human phosphoglycerate kinase 1 (PGK1) induces a multidrug resistance phenotype.
Duan, Z., Lamendola, D. E., Yusuf, R., Penson, R. T., Preffer, F. I., & Seiden, M. V. (2002) · PubMed · Cited by 83
Schneider, P. M., Praeuer, H. W., Stoeltzing, O., Boehm, J., Manning, J. T., Metzger, R., Fink, U., Wegerer, S., Hoelscher, A. H., & Roth, J. A. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1287 · Cited by 81
Koomägi, R., Mattern, J., & Volm, M. (1999) · PubMed · Cited by 66
Clinical Factors and Prognosis in Non–Small Cell Lung Cancer
Martins, S. J., & Pereira, J. R. (1999) · American Journal of Clinical Oncology · doi:10.1097/00000421-199910000-00006 · Cited by 61
Durany, N., Joseph, J., Campo, E., Molina, R., & Carreras, J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.168 · Cited by 56
Belfi, C. A., Chatterjee, S., Gosky, D. M., Berger, S. J., & Berger, N. A. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0472 · Cited by 50
Cited by
_, _. (2008) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2008.0021 · Cited by 735
A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer
Potti, A., Mukherjee, S., Petersen, R., Dressman, H. K., Bild, A., Koontz, J., Kratzke, R., Watson, M. A., Kelley, M., Ginsburg, G. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060467 · Cited by 576
RetractedHuman body fluid proteome analysis
Hu, S., Loo, J. A., & Wong, D. T. (2006) · PROTEOMICS · doi:10.1002/pmic.200600284 · Cited by 533
Roles of p53, MYC and HIF-1 in regulating glycolysis–the seventh hallmark of cancer
Yeung, S. J., Pan, J., & Lee, M.-H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8224-x · Cited by 514
Fan, T. W., Lane, A. N., Higashi, R. M., Farag, M. A., Gao, H., Bousamra, M., & Miller, D. M. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-41 · Cited by 434
Metadata
- Authors
- Chen, G., Gharib, T. G., Wang, H., Huang, C.-C., Kuick, R., Thomas, D. G., Shedden, K. A., Misek, D. E., Taylor, J. M. G., Giordano, T. J., Kardia, S. L. R., Iannettoni, M. D., Yee, J., Hogg, P. J., Orringer, M. B., Hanash, S. M., & Beer, D. G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-10-22
- Volume
- 100
- Issue
- 23
- Pages
- 13537-13542
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2150114991
- Cited by
- 277
- References
- 24
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.